NHI coverage to extend for anti-cancer drugs from Sept.
Published: 2005-09-01 06:59:00
Updated: 2005-09-01 06:59:00
Effective from Sept. 1, the NHI coverage will be extended to the anti-cancer drugs, anti-vomiting drugs and narcotic pain killers for cancer pains, including anastrozole (Amylidex tab.), capecitabine (Zeloda tab.) and enocitabine inj. (Sunlabine inj.).
In addition, the patient's pocket money f...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
